Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-17
2006-01-17
Russel, Jeffrey Edwin (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S321000
Reexamination Certificate
active
06987090
ABSTRACT:
The present invention discloses a hair growth promoting agent comprising a cyclosporin derivative as an active ingredient, and more particularly, a hair growth promoting agent comprising a cyclosporin A derivative in which sarcosine is substituted with thiosarcosine in the 3-position as an active ingredient.
REFERENCES:
patent: 4771122 (1988-09-01), Seebach
patent: 5807820 (1998-09-01), Elias
patent: 5948884 (1999-09-01), Luchinger
patent: 5965527 (1999-10-01), Barriere et al.
patent: 5994299 (1999-11-01), Barriere et al.
patent: 6521595 (2003-02-01), Kim et al.
patent: 6762164 (2004-07-01), Kim et al.
patent: 6790830 (2004-09-01), Kim et al.
patent: 2001/0025025 (2001-09-01), Viskov
patent: 2002/0165133 (2002-11-01), Kim et al.
patent: 0 414 632 (1996-10-01), None
patent: 2 218 334 (1989-11-01), None
patent: 60-243008 (1985-12-01), None
patent: 62-019512 (1987-01-01), None
patent: 62-019513 (1987-01-01), None
patent: WO 93/17039 (1993-09-01), None
patent: WO 00/51558 (2000-09-01), None
patent: WO 01/35913 (2001-05-01), None
patent: WO 02/092032 (2002-11-01), None
Maurer et al., “Hair Growth Modulation by Topical Immunophilin Ligands,”American Journal of Pathology, 1997, pp. 1433-1441, vol. 150, No. 4.
Eberle et al., “Cyclosporin A: Regioselective Ring Opening and Fragmentation Reactions via Thioamides. A Route to Semisynthetic Cyclosporins,”J. Org. Chem., 1994, pp. 7249-7258, vol. 59, No. 24.
Lutz, “Effects of Cyclosporin A on Hair,”Skin Pharmacol., 1994, pp. 101-104, vol. 7.
Eberle et al., “Preparation of [D-Cysteine]-cyclosporin via Intramolecular Sulfur Transfer Reaction,”J. Org. Chem., 1993, pp. 673-677, vol. 58, No. 3.
Seebach et al., “Thiocyclosporins: Preparation, Solution and Crystal Structure, and Immunosuppressive Activity,”Helv. Chim. Acta, 1991, pp. 1953-1990, vol. 74.
Gilhar et al., “Topical cyclosporine in male pattern alopecia,”J. Am. Acad. Dermatol., 1990, pp. 251-253, vol. 22, No. 2.
Gupta et al., “Oral cyclosporine for the treatment of alopecia areata,”J. Am. Acad. Dermatol., 1990, pp. 242-250, vol. 22, No. 2.
Von Traber et al., “Novel Cyclosporins forTolypocladium inflatum. The Cyclosporins K-Z,”Helv. Chim. Acta, 1987, pp. 13-36, vol. 70.
Yamamoto et al., “Hair Growth-Stimulating Effects of Cyclosporin A and FK506, Potent Immunosuppressants,”Journal of Dermatological Science7 (Suppl.), 1994, pp. 547-554.
Borel et al., “In Vivo Pharmacological Effects of Ciclosporin and Some Analogues,”Advances in Pharmacology, vol. 35, 1996, Exhibit A. pp. 115, 178, 179.
Paus et al., “Hair Growth Control by Immunosuppression,”Arch. Dermatol. Res.(1996) 288:408-410 (see in particular Table 1) (Exhibit B).
Kim Hyung-Jin
Kim Jong-Il
Kim Moon-Moo
Kim Sang-Nyun
Kim Seung-Jin
LG Household & Health Care Ltd.
Russel Jeffrey Edwin
The Webb Law Firm
LandOfFree
Use of 3-position cyclosporin derivatives for hair growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of 3-position cyclosporin derivatives for hair growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 3-position cyclosporin derivatives for hair growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3604196